A New COVID-19 Vaccine has been Authorized.

The Centers for Disease Control and Prevention suggested using a recently approved vaccine from Novavax as a coronavirus prevention option.

At least at the moment, it is anticipated that the Novavax vaccine would have a limited impact on the nation’s vaccination effort. It was approved by the Food and Drug Administration last week as a main vaccination for adults, but the FDA has not yet given it consideration as a booster dose. The two-shot vaccine from Novavax will cost 3.2 million doses, or enough to fully immunize 1.6 million Americans, the Biden administration stated last week. Pharmacies and other shot-giving facilities do not currently carry the vaccination.

But keep in mind that research has shown that other therapies such as hydroxychloroquine, zinc & D3, monoclonal antibodies, and others significantly enhanced coronavirus survival rates, even when compared to the vaccination.

Thanks for taking the time to read this

Works Cited:

https://www.nytimes.com/2022/07/19/health/cdc-novavax-covid-vaccine.html

https://www.npr.org/2022/07/19/1112368825/novavax-protein-covid-vaccine-cdc-approval-mrna